Nissan Chemical Corporation

4021.T · Basic Materials · Chemicals · Valued as of 2026-11-04 · Statements 2026-03-31

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

What it is worth

EPV + Growth

4.15B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

3.84B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

3.86B USD

15 years of cash for shareholders and lenders, less what is owed

Average Intrinsic Value

3.95B USD

The plain average of EPV, Profit and FCFF

Against the price

Market Cap

7.15B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.55×

the ratio the screener ranks by

Margin of Safety

-80.9%

1 − Market Cap / Average Intrinsic Value

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

Earnings power value plus growth: 4.15B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)4.16B USD
−②Net Debt Today17.01M USD
+③Growth Value0 USD
=Value4.15B USD

EPV of the Operations (NOPAT over WACC)

4.16B USD

Net debt today

-17.01M USD

Growth Value

0 USD

Value

4.15B USD

①EPV (Earnings Power Value)

4.16B USD

②Net Debt Today

17.01M USD

③Growth Value

0 USD

Market value

Market Cap7.15B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-72.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 3.84B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE2.71B USD
+②Equity at Year 15, Today1.13B USD
=Value3.84B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

2.71B USD

②Equity at Year 15, Today

1.13B USD

Market value

Market Cap7.15B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-86.1%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 3.86B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF2.61B USD
+②Invested Capital at Year 15, Today1.27B USD
−③Net Debt Today17.01M USD
=Value3.86B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

2.61B USD

②Invested Capital at Year 15, Today

1.27B USD

③Net Debt Today

17.01M USD

Market value

Market Cap7.15B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-84.9%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.06%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.46×Market Risk Premium 6.00%= 7.27%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 96.43M USDPretax Income 412.68M USD= 23.37%

The tax the interest saves.

Interest Expense =EBIT 415.16M USD−Pretax Income 412.68M USD= 2.48M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 2.48M USDTotal Debt 240.76M USD×(1 − Tax Rate for WACC 23.37%)= 0.79%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 240.76M USDMarket Cap + Total Debt 7.15B USD + 240.76M USD= 3.26%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 96.74%×Cost of Equity 7.27%+Debt Weight 3.26%×Cost of Debt 0.79%= 7.06%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 2.22B USD − Total Liabilities 601.37M USD = Book Value Today 1.62B USD

Total Debt 240.76M USD − Cash and Short-Term Investments 223.75M USD = Net Debt Today 17.01M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-3.2%at most 5%passes134,108,585 / 138,613,351
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets4.1%at least -10.0%passes(401.83M USD − 311.29M USD) ÷ 2.22B USD
Price to bookMarket Cap ÷ Book Value Today4.40×at most 3×does not pass7.15B USD ÷ 1.62B USD
Operating marginOperating Income ÷ Revenue22.7%above 10.0%passes397.99M USD ÷ 1.75B USD
Revenue growthRevenue ÷ Revenue a Year Before − 14.1%above 10.0%does not pass1.75B USD / 1.68B USD
Net cash(Cash − Total Debt) ÷ Market Cap-0.2%above -30%passes(223.75M USD − 240.76M USD) ÷ 7.15B USD
Operating efficiencyOperating Income ÷ Gross Profit48.5%above 25.0%passes397.99M USD ÷ 820.00M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

8400.39 JPY

Enterprise value

1.13T JPY

the provider's own figure

EV / EBITDA

13.63×

Price / book

4.46×

the provider's book

Price / earnings

22.76×

Return on equity

21.8%

the provider's figure, not this page's

Profit margin

18.3%

Revenue growth

12.8%

Analyst target, mean

9142.46 JPY

Analysts

9

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

Income statement (USD)2023202420252026

Revenue

1.71B1.50B1.68B1.75B

Gross profit

802.62M692.54M779.71M820.00M

Operating income

392.91M318.61M380.24M397.99M

EBITDA

operating income before depreciation and amortisation

509.78M436.99M498.41M512.31M

Pretax income

425.38M342.29M397.88M412.68M

Net income

308.77M251.39M287.98M311.29M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

308.83M255.24M285.19M316.86M

R&D

————
Balance sheet, year end (USD)2023202420252026

Total assets

2.24B2.14B2.21B2.22B

Total liabilities

580.08M611.46M632.81M601.37M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.64B1.50B1.56B1.60B

Total debt

205.08M270.87M270.79M240.76M

Cash and equivalents

222.80M150.30M183.68M223.75M

Net PP&E

fixed assets after depreciation

485.86M511.42M484.55M482.01M

Working capital

current assets less current liabilities

881.45M762.81M877.34M899.74M
Cash flow (USD)2023202420252026

Operating cash flow

264.72M222.76M395.93M401.83M

Capital expenditure

paid out, so below zero

-151.60M-138.79M-122.89M-128.80M

Depreciation and amortisation

82.51M91.22M96.15M97.15M

Free cash flow

operating cash flow plus capital expenditure

113.12M83.97M273.04M273.03M